PT-141 female dosage is typically 1.75 mg injected subcutaneously as needed. Learn approved dosing, reconstitution, and safety in this guide.
The FDA-approved PT-141 (bremelanotide) dosage for premenopausal women is 1.75 mg injected subcutaneously, as needed, at least 45 minutes before anticipated sexual activity. Women should not use more than one dose in 24 hours or more than eight doses per month. This dose is sold under the brand name Vyleesi and is intended for hypoactive sexual desire disorder (HSDD), not for recreational use.
What Is PT-141 and How Does It Work in Women?
PT-141 is a melanocortin receptor agonist that acts on the central nervous system to increase sexual desire. It is not a hormone and does not work like testosterone or estrogen. The FDA approved bremelanotide for premenopausal women with acquired, generalized HSDD in 2019. Bremelanotide is given as a subcutaneous injection into the abdomen or thigh. It bypasses the digestive system, so it works faster than an oral pill.
PT-141 is not a cure for relationship problems, medication side effects, or other causes of low libido. A healthcare professional should evaluate underlying causes before prescribing PT-141.
PT-141 Female Dosage Chart: Approved Guidelines
The table below serves as a pt-141 peptide dosage chart for approved female use. It reflects the label instructions for Vyleesi, the only FDA-approved brand of bremelanotide.
| Parameter | Recommendation |
|---|---|
| Dose | 1.75 mg (0.175 mL of 10 mg/mL solution) |
| Route | Subcutaneous injection (abdomen or thigh) |
| Timing | At least 45 minutes before sexual activity |
| Frequency | Maximum once per 24 hours |
| Monthly limit | Maximum 8 doses per month |
| Approved population | Premenopausal women with HSDD |
The table above summarizes the standard pt-141 dosage protocol for women. Deviating from this protocol increases the risk of side effects without proven benefit. Some women may experience side effects at the approved dose. If side effects are intolerable, a healthcare professional may recommend stopping the medication rather than adjusting the dose on your own.
How to Calculate PT-141 Dosage in mL After Reconstitution
If you have a lyophilized (powder) vial of PT-141, you must reconstitute it with bacteriostatic water before injection. To determine pt-141 dosage in ml, divide the desired milligram dose by the concentration of the reconstituted solution.
For example, a 10 mg vial reconstituted with 1 mL of water yields 10 mg/mL. A 1.75 mg dose would be 0.175 mL. If the same vial is reconstituted with 2 mL, the concentration is 5 mg/mL, and 1.75 mg equals 0.35 mL.
Use a pt-141 dosage calculator for women to avoid arithmetic errors. Never guess the volume because small mistakes can lead to a large overdose.
Proper pt-141 reconstitution and dosage technique includes swabbing the vial stopper with alcohol, injecting the water slowly down the side of the vial, and gently swirling—never shaking—until dissolved. Store reconstituted peptide in the refrigerator and follow the manufacturer's expiration guidance. For a 10 mg vial, you might add 1 mL, 2 mL, or 3 mL of bacteriostatic water. The concentration changes with each volume, so the injection volume changes too. Always label the vial with the date and concentration.
Off-Label and Male Dosing: What Research Shows
PT-141 is not FDA-approved for men. Some researchers and clinicians have studied male dosing of 1.75 mg to 2 mg, with some trials using up to 2.5 mg. However, higher doses are associated with more nausea and blood pressure increases. Clinical trials for female HSDD did not show a consistent benefit for doses above 1.75 mg, but they did show more nausea. That is why the approved dose remains 1.75 mg.
PT-141 is not an anabolic steroid. Its primary effects are on sexual desire and flushing, not on muscle protein synthesis. People who ask about PT-141 for bodybuilding are usually confusing it with other peptides.
Men should not assume the female dose applies to them. A healthcare professional can provide individualized guidance, but any male use is off-label and carries additional uncertainty.
Safety, Side Effects, and Who Should Avoid PT-141
- Nausea (most common, affecting about 40% of users)
- Flushing, headache, vomiting
- Injection site reactions
- Transient increases in blood pressure
- Hyperpigmentation with frequent use
- Focal seizures (rare)
PT-141 is contraindicated in women with uncontrolled hypertension or known cardiovascular disease. It should not be used with MAO inhibitors or within 2 weeks of stopping an MAOI.
PT-141 can cause a small, temporary rise in blood pressure. Women should check their blood pressure before starting and monitor for symptoms like dizziness or chest pain. PT-141 should not be used during pregnancy or breastfeeding because safety has not been established.
Do not use PT-141 more than once in 24 hours. If you miss a dose, skip it and wait until the next day.
What to Discuss with Your Healthcare Provider
Before starting PT-141, discuss your medical history, current medications, and blood pressure with a licensed healthcare professional. Ask whether a lower starting dose or a different treatment is appropriate for you.
PT-141 is a prescription medication in the United States. Buying peptides from unregulated sources carries risks of impurities, incorrect dosing, and infection. If you are postmenopausal, PT-141 is not FDA-approved for you, although some clinicians may prescribe it off-label.
Your healthcare provider can also help you set realistic expectations. PT-141 does not work for everyone, and it is not a substitute for addressing relationship or psychological factors that affect sexual desire.
Frequently Asked Questions
What is the correct PT-141 dosage for women?
The FDA-approved PT-141 dosage for premenopausal women is 1.75 mg injected subcutaneously as needed, at least 45 minutes before sexual activity. Do not exceed one dose in 24 hours or eight doses per month. Any other dose is off-label.
How many mL of PT-141 is 1.75 mg?
The volume depends on the concentration after reconstitution. If you mix a 10 mg vial with 1 mL of water, the concentration is 10 mg/mL, so 1.75 mg equals 0.175 mL. If you mix with 2 mL, the concentration is 5 mg/mL, so 1.75 mg equals 0.35 mL.
Is PT-141 safe for women to use daily?
No. PT-141 is not intended for daily use. The approved schedule is as needed, with a maximum of one dose in 24 hours and no more than eight doses per month. More frequent use increases the risk of nausea, blood pressure changes, and hyperpigmentation.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.